rawfin.tv
Developer Acquires Former Pfizer Biomanufacturing Plant in Everett
MarketsstocksAI Generated

Developer Acquires Former Pfizer Biomanufacturing Plant in Everett

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

A California developer has purchased the unfinished $350 million biomanufacturing facility in Everett, previously halted by Pfizer. The acquisition includes securing a new, undisclosed tenant for the site.

PfizerReal EstateBiomanufacturingCorporate Development

Related Articles

China Equities Lag US Stocks by Record 2.095 Valuation Ratio

China Equities Lag US Stocks by Record 2.095 Valuation Ratio

stocks
S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

stocks
Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

stocks
Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

stocks